Oren Ilan's Form 4 filing
Roivant Sciences Ltd. (ROIV) · filed Jul 21, 2026
- Accession no.
- 0001140361-26-029191
- Filed
- Jul 21, 2026, 9:00 PM ET
- Trade date
- Jul 17, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Oren IlanCIK 0001643073 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 17, 2026 | Common Shares | AGrant or awardAcquired | +775 | $0.00F1 | $0 | 121,004 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Reflects an award of Common Shares received pursuant to the Issuer's Non-Employee Director Compensation Plan that was fully vested as of the grant date.
Referenced by the price of 1 transaction in Table I.
Remarks
Exhibit 24 - Power of Attorney